Previous Article | Next Article ![]()
Molecular and Cellular Biology, September 2001, p. 5869-5878, Vol. 21, No. 17
Lautenberg Center for General and Tumor
Immunology, The Hebrew University Hadassah Medical School, Jerusalem
91120,1 and Department of Biochemistry,
The Rappaport Family Institute for Research in the Medical Sciences
and the Bruce Rappaport Faculty of Medicine, Technion-Israel Institute
of Technology, Haifa 31096,2 Israel
Received 8 March 2001/Returned for modification 11 May
2001/Accepted 4 June 2001
The p53 protein is subject to Mdm2-mediated degradation by the
ubiquitin-proteasome pathway. This degradation requires interaction between p53 and Mdm2 and the subsequent ubiquitination and nuclear export of p53. Exposure of cells to DNA damage results in the stabilization of the p53 protein in the nucleus. However, the underlying mechanism of this effect is poorly defined. Here we demonstrate a key role for c-Abl in the nuclear accumulation of endogenous p53 in cells exposed to DNA damage. This effect of c-Abl is
achieved by preventing the ubiquitination and nuclear export of p53 by
Mdm2, or by human papillomavirus E6. c-Abl null cells fail to
accumulate p53 efficiently following DNA damage. Reconstitution of
these cells with physiological levels of c-Abl is sufficient to promote
the normal response of p53 to DNA damage via nuclear retention. Our
results help to explain how p53 is accumulated in the nucleus in
response to DNA damage.
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.17.5869-5878.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
c-Abl Regulates p53 Levels under Normal and Stress Conditions
by Preventing Its Nuclear Export and Ubiquitination
*
Corresponding author. Mailing address: Lautenberg
Center for General and Tumor Immunology, The Hebrew University Hadassah Medical School, Jerusalem 91120, Israel. Phone: 972-2-6757103. Fax:
972-2-6424653. E-mail: haupt{at}md.huji.ac.il.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|